A randomized double-blind controlled trial of compound kra dook kai dam medicated spray versus topical diclofenac spray for the treatment of mild to moderate soft tissue injury

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20180523005

Enrollment

100

Registered

2018-05-23

Start date

2018-02-21

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild to moderate soft tissue injury

Interventions

Spray to pain area 2 puff three time a day,Spray to pain area 2 puff three time a day

Experimental Drug,Active Comparator Drug

Muscool spray,Diclofenac spray

Eligibility

Sex/Gender

All

Age

15 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. One of these diagnosis from orthopedic specialist 1.1 Shoulder sprain 1.2 Elbow sprain 1.3 Wrist sprain 1.4 Metacarpophalangeal joint sprain 1.5 Interphalangeal joint sprain 1.6 Hip sprain 1.7 Knee sprain 1.8 Ankle sprain 1.9 Metatarsophalangeal joint sprain 1.10 Foot sprain 1.11 Neck strain 1.12 Back strain 1.13 Back contusion

Exclusion criteria

Exclusion criteria: 1. Joint dislocation 2. Open skin lesions within the pain area 3. The symptoms of a skin infection within the pain area 4. patients with known hypersensitivity to Diclofenac and Acanthaceae species plant 5. Pregnant and breast-feeding women

Design outcomes

Primary

Measure	Time frame
Pain score At 1 week Visual analog scale	—

Secondary

Measure	Time frame
Swelling At 1 week Clinician diagnosis	—

Countries

Thailand

Contacts

Public ContactNatdanai Musigavong

Unaffiliated

mnatdanai@hotmail.com037211289

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

A randomized double&#45;blind controlled trial of compound kra dook kai dam medicated spray versus topical diclofenac spray for the treatment of mild to moderate soft tissue injury